Consistent with this, IL-34 knockdown in CRC cells with an antisense oligonucleotide (ASO) inhibited ERK1/2 activation, thereby resulting in reduced cell proliferation [59] (Fig. 2). This evidence concerns the gene MAPK3 and colorectal carcinoma.